Is this stock's 7.5% dividend yield too good to be true?

Commonwealth Bank of Australia (ASX:CBA) might have dropped in price, but it's by no means a bargain.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the most important lessons an investor can learn is to never base a decision solely around a stock's dividend yield. Although it might play a big part in the final decision, there are so many other factors that also need to be considered before you press that "Buy" button.

Commonwealth Bank of Australia (ASX: CBA) is a perfect example of this. While the stock has fallen more than 9% since peaking in July, many investors have been wondering whether now is the time to pounce and take advantage of its tantalising $4.01 per share dividend. At $76.34, that's a grossed up yield of 7.5%!

Indeed, in this low interest rate environment, that yield is far better than what investors could expect to receive in interest from term deposits or from government bonds. However, those investors who choose to buy now could also be committing themselves to years of underperformance.

Even at today's lower price, the stock still demands an excessive premium. Although the dividend might be attractive, I'd be willing to bet that the capital returns will be very limited in the coming years. Who knows, with all the risks facing the financial sector, maybe we'll even see the shares drop considerably over the next few years.

For example, investors need to weigh up whether the inflated housing market or the tumbling Aussie dollar will impact the share price. Likewise, they need to consider whether new capital requirements that are likely to be imposed on the big four banks will change CBA's ability to grow or even maintain its current dividend payments.

When these factors are considered, is it really worth taking the risk for what could potentially be a very small capital return?

As it stands, Commonwealth Bank of Australia is trading on a P/E ratio of 14.4. Although that is lower than the market's average (roughly 15.3), it is still excessive considering the bank's limited growth opportunities in the coming years. Given the headwinds facing the sector, investors who choose to buy Commonwealth Bank now for its lucrative dividend could be in for a rude surprise in the future.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »